Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PFMT Stock Forecast 2026-2027
$7.75
Current Price
$596.13M
Market Cap
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to PFMT Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
PFMT Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
+211.2%
1 Year Change
0.0%
Year-to-Date Change
-0.1%
From 52W High of $7.76
+257.1%
From 52W Low of $2.17
📊 TOP ANALYST CALLS
Did PFMT Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Performant is one of their latest high-conviction picks.
Latest PFMT Stock Price Targets & Analyst Predictions
PFMT has shown a year-to-date change of 0.0% and a 1-year change of 211.2%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for PFMT. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PFMT Analyst Ratings
3
Buy
0
Hold
0
Sell
PFMT Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $7.75
Latest PFMT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PFMT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 7, 2024 | B. Riley Securities | Kyle Bauser | Buy | Maintains | $7.00 |
| Jul 25, 2024 | B. Riley Securities | Kyle Bauser | Buy | Initiates | $8.00 |
| Dec 20, 2022 | Lake Street | Jacob Stephan | Buy | Assumes | $8.00 |
| Jul 7, 2021 | Craig-Hallum | George Sutton | Buy | Initiates | $10.00 |
| Jun 4, 2021 | Colliers Securities | Buy | Initiates | $N/A | |
| Jan 12, 2018 | Compass Point | Buy | Upgrade | $N/A | |
| Dec 12, 2016 | Compass Point | Neutral | Downgrade | $N/A | |
| Feb 27, 2015 | Compass Point | Neutral | Downgrade | $N/A | |
| Nov 25, 2014 | Macquarie | Neutral | Initiates | $N/A | |
| Nov 10, 2014 | Morgan Stanley | Equal-Weight | Downgrade | $9.00 | |
| Nov 7, 2014 | William Blair | Market Perform | Downgrade | $N/A | |
| Oct 8, 2014 | Compass Point | Buy | Maintains | $11.00 | |
| Jun 12, 2014 | SunTrust Robinson Humphrey | Buy | Maintains | $N/A | |
| Jun 11, 2014 | SunTrust Robinson Humphrey | Buy | Maintains | $11.75 | |
| Feb 28, 2014 | Credit Suisse | Neutral | Downgrade | $8.00 | |
| Feb 28, 2014 | Compass Point | Buy | Maintains | $11.00 | |
| Feb 28, 2014 | Morgan Stanley | Overweight | Maintains | $12.00 | |
| Feb 28, 2014 | SunTrust Robinson Humphrey | Buy | Upgrade | $10.00 | |
| Feb 21, 2014 | Wells Fargo | Market Perform | Downgrade | $N/A | |
| Jan 21, 2014 | Compass Point | Buy | Maintains | $13.00 |
Performant Healthcare, Inc. (PFMT) Competitors
The following stocks are similar to Performant based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Performant Healthcare, Inc. (PFMT) Financial Data
Valuation Metrics
Market Cap
$596.13M
Enterprise Value
$594.43M
P/E Ratio
-77.5x
PEG Ratio
-0.4x
Price/Sales
5.2x
Growth & Margins
Revenue Growth (YoY)
+7.3%
Gross Margin
N/A
Operating Margin
-5.2%
Net Margin
N/A
EPS Growth
+5.2%
Financial Health
Cash/Price Ratio
N/A
Current Ratio
2.7x
Debt/Equity
0.1x
ROE
-9.3%
ROA
-7.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Performant Healthcare, Inc. (PFMT) Business Model
About Performant Healthcare, Inc.
What They Do
Provides payment integrity and eligibility services.
Business Model
The company generates revenue by offering audit, recovery, and consulting services to healthcare payers and providers. By identifying improper payments and optimizing revenue cycles, Performant helps clients enhance their financial performance, particularly in sectors such as Medicaid, Medicare, and commercial insurance.
Additional Information
Performant focuses on technology-driven solutions that modernize healthcare financial management, allowing clients to concentrate on patient care and quality improvement. Its comprehensive managed services and actionable insights position it as a vital contributor to the efficiency and sustainability of healthcare financing.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
958
CEO
Mr. Simeon M. Kohl
Country
United States
IPO Year
2012
Website
performantcorp.comPerformant Healthcare, Inc. (PFMT) Latest News & Analysis
Latest News
Quick Summary
Performant Healthcare, Inc. will change its Nasdaq ticker symbol from "PFMT" to "PHLT" on December 18, 2024, marking its focus on healthcare payment integrity solutions.
Why It Matters
The ticker change to "PHLT" signals Performant's strategic shift to focus on healthcare payment integrity, potentially attracting investors looking for specialized growth in this sector.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Performant Financial Corporation has rebranded to Performant Healthcare, Inc. and will change its ticker symbol to PHLT. This change does not affect its operations or management.
Why It Matters
The name change to Performant Healthcare and new ticker symbol PHLT signal a strategic focus shift, potentially influencing investor perception and market positioning in the healthcare sector.
Source: Business Wire
Market Sentiment:
Neutral
Performant to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
1 year ago
Quick Summary
Performant Financial Corporation (Nasdaq: PFMT) will participate in the Noble Capital Markets Emerging Growth Equity Conference on December 3rd, with CEO Simeon Kohl presenting updates, including on New York State Medicaid.
Why It Matters
Performant Financial's participation in a prominent investment conference signals its growth potential and strengthens visibility, which could influence stock performance and investor interest.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Performant Financial's Q3/2024 results met consensus expectations. A reduction in customer care services may impact revenue, but management maintains full-year profitability and healthcare revenue forecasts.
Why It Matters
Performant Financial's aligned Q3 results and reduced customer care services may hinder growth, yet reaffirmed profitability projections offer stability amid external challenges.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Performant Financial Corporation (Nasdaq: PFMT) will attend the 15th Annual Craig-Hallum Alpha Select Conference in NYC on November 19, 2023, to discuss updates and engage with investors.
Why It Matters
Performant Financial's participation in the conference signals engagement with investors and potential positive updates, likely influencing stock performance and market sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Performant Financial Corporation (PFMT) held its Q3 2024 earnings call, detailing financial performance and strategic updates for investors. Further specifics on earnings metrics were discussed.
Why It Matters
The Q3 2024 earnings call for Performant Financial Corporation (PFMT) provides insights into financial performance, growth prospects, and market positioning, influencing investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About PFMT Stock
What is Performant Healthcare, Inc.'s (PFMT) stock forecast for 2026?
Analyst forecasts for Performant Healthcare, Inc. (PFMT) are not currently available. The stock is trading at $7.75.
Is PFMT stock a good investment in 2026?
According to current analyst ratings, PFMT has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.75. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PFMT stock?
Price predictions from Wall Street analysts for PFMT are not currently available. The stock is trading at $7.75.
What is Performant Healthcare, Inc.'s business model?
The company generates revenue by offering audit, recovery, and consulting services to healthcare payers and providers. By identifying improper payments and optimizing revenue cycles, Performant helps clients enhance their financial performance, particularly in sectors such as Medicaid, Medicare, and commercial insurance.
What is the highest forecasted price for PFMT Performant Healthcare, Inc.?
Price targets from Wall Street analysts for PFMT are not currently available. The stock is trading at $7.75.
What is the lowest forecasted price for PFMT Performant Healthcare, Inc.?
Price targets from Wall Street analysts for PFMT are not currently available. The stock is trading at $7.75.
What is the overall PFMT consensus from analysts for Performant Healthcare, Inc.?
The overall analyst consensus for PFMT is bullish. Out of 4 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell.
How accurate are PFMT stock price projections?
Stock price projections, including those for Performant Healthcare, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 19, 2026 7:20 PM UTC